Abstract
Catechin (an anti-inflammatory, antioxidant, antitumour, and hepatoprotective bioflavonoid) is poorly absorbed across the GIT because it has multiple ring molecules that are too large to be absorbed by simple diffusion. It typically has poor miscibility with oils and other lipids which limit their ability to pass across the lipid rich outer membranes of enterocytes of small intestine. Thus catechin–phospholipid complex were prepared to improve its absorption by imparting an environment of improved lipophilicity. The phospholipid complexes of catechin were prepared with phosphatidylcholine in presence of dichloromethane by conventional solvent evaporation technique. Pharmacosomes thus prepared were evaluated for solubility, drug content, scanning electron microscopy (SEM), differential scanning calorimetry (DSC), X ray powder diffraction (XRPD), in vitro dissolution study and in vitro antioxidant activity. Prepared phospholipid complex showed high drug content (99.40%. w/w) and improved lipid solubility (0.79–1.97 mg/mL). FTIR, NMR, DSC and XRPD data confirmed the formation of phospholipid complex. Unlike the free catechin, catechin complex showed a sustained release over the 24 h of study. Catechin-phospholipid complex showed slightly better antioxidant activity than that of catechin at all dose levels. Thus it can be concluded that the phospholipid complex of catechin may be of potential use for improving absorption of catechin across the lipidic biological barriers in gastrointestinal tract. It was concluded that the complexation with phospholipids did not interfere with the biological activities. This herbal drug delivery system can pave the way for large molecules to pass through the lipophilic biological membrane (by the virtue of their amphiphilic nature) and get absorbed into the systemic circulation.
Similar content being viewed by others
References
Kalender, S., Kalender, Y., Ates, A., Yel, M., Olcay, E., Candan, S.: Protective role of antioxidant vitamin E and catechin on idarubicin induced cardiotixicity in rats. Bra. J. Med. Bio. Res. 34, 1379–1387 (2002)
Kid, P., Head, K.: A review of the bioavailability and clinical efficacy of milk thistle phytosome: a Silybin–phosphatidylcholine complex. Alt. Med. Rev. 11, 12–15 (2005)
Reimann, H.J., Lorenz, W., Fisher, M., Meyer, H.J., Schmal, A., Frolich, R.: Histamine & acute haermorrhagic lesions in rat gastric mucosa; prevention of stress ulcer formation by (+)- catechin, an inhibitor of specific histidine decarboxylase in vitro. Inflammation Res. 7(1), 69–73 (1977)
Rivkind, A.I., Marshood, M., Durst, A.L., Becker, Y.: Cianidanol ([+]–cyanidanol-3) prevents the development of abdominal adhesions in rats. Arch. Surgery. 118(12), 14–17 (1983)
Weyant, M.J., Carothers, A.M., Bertagnolli, M.M., Dannerberg, A.J.: [+]–catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the Min/+ mouse. Cancer Res. 61, 118–125 (2001)
Takano, F., Tanaka, T., Aoi, J., Yahagi, N., Fushiya, S.: Protective effect of (+) -catechin against 5-fluorouracil induced myelosuppression in mice. Toxicology. 201(1–3), 133–142 (2004). doi:10.1016/j.tox.2004.04.009
Singal, S.K., Tirkey, N., Chopra, K.: Green tea extract and catechin ameliorate chronic fatigue induced oxidative stress in mice. J. Medicinal Food. 8(1), 47–52 (2005). doi:10.1089/jmf.2005.8.47
Parvaz, S., Jabassum, H., Rehman, H., Benarjee, B., Athar, M., Raisuddin, S.: Catechin prevents tamoxifen induced oxidative stress and biochemical perturbations in mice. Toxicology. 225(2–3), 109–118 (2006). doi:10.1016/j.tox.2006.05.009
Siegers, C.P., Volpel, M., Scheel, G., Younes, M.: Effect of dithiocarb & catechin against CCl4-alcohol induced liver fibrosis. Agents Actions. 12(5), 743–748 (1982). doi:10.1007/BF01965096
Varga, M., Buris, L.: Some morphometric evidence of hepatoprotective effects of (+) cyanidanol -3. Pharmacol. Biochem. Behav. 33(3), 523–526 (1989). doi:10.1016/0091-3057(89)90380-8
Semalty, A., Semalty, M., Rawat, B.S., Singh, D., Rawat, M.S.M.: Pharmacosomes: the lipid based novel drug delivery system. Expert. Opin. Drug Deliv. 6, 599–612 (2009). doi:10.1517/17425240902967607
Semalty, A., Semalty, M., Singh, D., Rawat, M.S.M.: Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J. Incl. Phenom. Macrocycl. Chem. 67, 253–260 (2010). doi:10.1007/s10847-009-9705-8
Blois, M.S.: Antioxidant determination by the use of a stable free radical. Nature 181, 1199–1200 (1958). doi:10.1038/1811199a0
Paradkar, A.R., Pawar, A.P., Chordiya, J.K., Patil, V.B., Ketkar, A.R.: Spherical crystallization of celecoxib. Drug Dev. Ind. Pharm. 28, 1213–1220 (2002). doi:10.1081/DDC-120015354
Yanyu, X., Yunmei, S., Zhipeng, C., Quineng, P.: The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm. 307, 77–82 (2006). doi:10.1016/j.ijpharm.2005.10.001
Li, Y., Yang, D.J., Chen, S.L., Chen, S.B., Chan, A.S.C.: Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm. Res. 25, 563–577 (2007). doi:10.1007/s11095-007-9418-x
Maiti, K., Mukherjee, K., Gantait, A., Saha, B.P., Mukherjee, P.K.: Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 330, 155–163 (2007). doi:10.1016/j.ijpharm.2006.09.025
Kumar, M., Ahuja, M., Sharma, S.K.: Hepatoprotective study of curcumin-soya lecithin complex. Sci. Pharm. 76, 761–774 (2008). doi:10.3797/scipharm.0808-09
Singh, D., Rawat, M.S.M., Semalty, A., Semalty, M.: Gallic acid-phospholipid complex: drug incorporation and physicochemical characterization. Lett. Drug Design Discov. 8, 2011, (BSP/LDDD/E-Pub/00114) In press
Shi, K., Cui, F., Yu, Y., Zhang, L., Tao, A., Cun, D.: Preparation and characterization of a novel insulin phospholipid complex. Asian J. Pharm. Sci. 1(3–4), 168–174 (2006)
Cui, F., Shi, K., Zhang, L., Tao, A., Kawashima, Y.: Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery : preparation, in vitro characterization and in vivo evaluation. J. Control. Release. 114, 242–250 (2006). doi:10.1016/j.jconrel.2006.05.013
Yoo, H.S., Park, T.G.: Biodegradable nanoparticles containing protein-fatty acid complex for oral delivery of salmon calcitonin. J. Pharm. Sci. 93, 488–495 (2003)
Semalty, A., Semalty, M., Singh, D., Rawat, M.S.M.: Development and physicochemical evaluation of pharmacosomes of diclofenac. Acta Pharma. 59, 335–344 (2009). doi:10.2478/v10007-009-0023-x
Semalty, A., Semalty, M., Rawat, B.S., Singh, D., Rawat, M.S.M.: Development and evaluation of pharmacosomes of aceclofenac. Indian J. Pharm. Sci. 72, 571–575 (2010). doi:10.4103/0250-474X.78522
Bombardelli, E., Curri, S.B., Gariboldi, P.: Cosmetic utilization of complexes of Panax ginseng saponins with phospholipids in PHYTOSOME® form. Fitoterapia. 60(S1), 55–70 (1989)
Jithan, A., Ganji, S.: Formulation, excipient properties and pharmacological activities of catechin liposomes. Phcog. Mag. 4(13), 121–126 (2008)
Soares, J.R., Dins, T.C.P., Cunha, A.P.: Antioxidant activity of some extracts of Thymus zygis. Free Rad. Res. 26, 469–478 (1997). doi:10.3109/10715769709084484
Semalty, A., Semalty, M., Rawat, M.S.M., Federico, F.: Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME® strategy to improve the bioavailability of phytochemicals. Fitoterapia 81, 306–314 (2010). doi:10.1016/j.fitote.2009.11.001
Acknowledgments
Authors acknowledge the grant provided by the University Grant Commission, Govt. of India for the research work. Authors are also thankful to LIPOID GmbH Germany for providing the gift sample of phosphatidylcholine for the research work. Facilities provided by the IIT Roorkee, NMR Laboratory, Faculty of Pharmacy Jamia Hamdard, New Delhi and Department of Chemistry, University of Delhi are thankfully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Semalty, A., Semalty, M., Singh, D. et al. Phyto-phospholipid complex of catechin in value added herbal drug delivery. J Incl Phenom Macrocycl Chem 73, 377–386 (2012). https://doi.org/10.1007/s10847-011-0074-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-011-0074-8